ArticleInsights into imaging2026
Interpretable chronic obstructive pulmonary disease identification using chest X-ray radiomics: a multicenter study.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectivesTo construct and validate a combined model integrating chest X-ray (CXR)-based radiomic features and clinical characteristics for chronic obstructive pulmonary disease (COPD) identification, while enhancing model interpretability. MATERIALS AND
methodsPaired CXR images and clinical data were collected from 17 hospitals between January 2017 and December 2023. Data from 11 centers were divided into a training cohort and an internal validation cohort at a 7:3 ratio, with data from the remaining 6 centers serving as an external validation cohort. Three models (radiomic model, clinical model, and combined model) were constructed, and the SHapley Additive exPlanations (SHAP) method was used to interpret model performance.
resultsA total of 2433 participants were enrolled, with a mean age of (66.9 ± 11.4) years, including 1564 males and 819 COPD patients. The radiomic model achieved AUCs of 0.760, 0.754, and 0.764 in the training, internal validation, and external validation cohorts, respectively, which were significantly higher than those of the clinical model (AUCs: 0.631, 0.651, and 0.673; all p < 0.001). SHAP analysis revealed that age, radiomic features, smoking history, and sex were crucial for COPD identification.
conclusionsThis study successfully constructed a CXR-based combined radiomic-clinical model for COPD, which demonstrated good performance and high accuracy in identifying COPD in this multicenter study. The SHAP method enhanced the model's interpretability and clinical applicability. CRITICAL RELEVANCE STATEMENT: This study develops a CXR radiomic-clinical COPD identification model with SHAP-enhanced interpretability, advancing interpretable, widely applicable COPD screening in clinical radiology. KEY POINTS: The clinical screening rate for COPD remains severely inadequate. The combined model integrating chest X-ray radiomic features and clinical variables enables accurate differentiation between patients with COPD and non-COPD individuals. Global SHAP analysis reveals that radiomic features are the primary factor influencing COPD identification, followed by age, sex, and smoking status. Local SHAP analysis can intuitively visualize the model's decision-making process at the individual sample level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.